AstraZeneca cut its supply forecast of Covid-19 vaccines to the European Union in the first quarter to about 30 million doses, a third of its contractual obligations and a 25 per cent drop from pledges made last month, a document seen by Reuters shows.
The shortfall will represent a further blow to the EU’s vaccination plans, which have been hampered by repeated delays in vaccine supplies and by a slow rollout in some nations.
The document, shared with EU officials and dated March 10, shows that the company now expects to deliver 30.1 million doses by the end of March, and another 20 million in April.
